Publications (78) Tomás Ramón Vázquez Rodríguez publications

2024

  1. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

    Seminars in Arthritis and Rheumatism, Vol. 68

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

  2. Injection site reaction with subcutaneous methotrexate

    Dermatologic Therapy

2021

  1. Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis

    Scientific Reports, Vol. 11, Núm. 1

  2. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

    Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336

2020

  1. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

  2. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224

2019

  1. Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients

    Reumatologia Clinica, Vol. 15, Núm. 1, pp. 54-57

  2. Tumor-induced hypophosphatemic osteomalacia: description of 2 cases

    Medicina Clinica

2018

  1. Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort

    Arthritis Research and Therapy, Vol. 20, Núm. 1

2017

  1. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430

2016

  1. Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)

    Medicine (United States), Vol. 95, Núm. 9

  2. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

2014

  1. Investigations into audiovestibular manifestations in patients with psoriatic arthritis

    Journal of Rheumatology, Vol. 41, Núm. 10, pp. 2018-2026

  2. Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: Subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 94-100

2013

  1. Pinzamiento isquiofemoral: dolor de cadera de causa poco frecuente

    Reumatologia Clinica, Vol. 9, Núm. 3, pp. 186-187

2012

  1. Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

    Mediators of Inflammation, Vol. 2012

  2. Association of ferritin autoantibodies with giant cell arteritis/ polymyalgia rheumatica

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 6, pp. 943-947

  3. Espondilodiscitis tuberculosa con tumoración lumbar

    Reumatologia Clinica, Vol. 8, Núm. 5, pp. 292-293

2011

  1. Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology